Monday, 28 September 2026Updated 10m ago
← Top stories
Policy● Neutral for Indian equities

Pharma PLI attracts over Rs 46,700 crore investments, but China still dominates API imports

1 source · first seen 19:32 25 Sept · updated 19:32 25 Sept

Tags on this story

Pick a tag to see all its stories
Pharma and healthcare19 todayChina26 todayManufacturing16 todayTrade and tariffs27 today

Linked by the tag Pharma and healthcare

61 stories this week
  1. 27 SeptFortis says independent audit will establish non-involvement in Singh brothers’ share transfersLegal · 2 sources · Supreme Court cleared the way for an independent forensic audit of the share transfers
  2. 27 SeptFortis confident of clean chit from audit in Singh brothers’ disputeLegal · 1 source · Fortis expects a clean chit from the audit in the Singh brothers’ dispute
  3. 25 SeptSupreme Court allows independent forensic audit of Fortis transactions in Daiichi disputeLegal · 6 sources · The Supreme Court declined to interfere with Delhi High Court orders allowing the audit
  4. 25 SeptRegulator mulls digital platform for drugmakers' test reportsPolicy · 1 source · India’s drug regulator is developing a digital platform for consumers to view batch-level quality-test reports
  5. 24 SeptMint Explainer | Why NHRC wants India’s drugs regulator to build a national digital registryPolicy · 1 source · NHRC wants the drugs regulator to build a national digital registry using QR codes and drug-tracking tools
All Pharma and healthcare stories →

Read the reports

1 report · earliest 19:32
Financial ExpressPharma PLI attracts over Rs 46,700 crore investments, but China still dominates API imports19:32